Lynda Nwabuobi is a Neurology physician. OpenAlex indexes 11 publications with 248 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2021 K St NW Ste 210
Washington, DC 200061003
Telephone
301-562-7200Provider last certified this registry record 5 Dec 2024.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year202522 payments
- Teva Pharmaceuticals USA, Inc.Program year20258 payments
- ABBVIE INC.Program year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
90.1%Neuromuscular Blocker90.1%Onabotulinumtoxina100%Part B, office-administered≥11 patientsNervous system
9.6%Aromatic Amino Acid Decarboxylation Inhibitor4.5%Carbidopa-Levodopa82%Carbidopa-Levodopa Er18%Part D≥39 patientsGabapentinoids1.4%Gabapentin62%Pregabalin38%Part D<11 patients+ 7 more classes in this area
Cardiovascular
0.3%Beta blocker0.3%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Racial and Social Disparities in Health and Health Care Delivery among Patients with Parkinson’s Disease and Related Disorders in a Multiracial Clinical Setting
Journal of Cross-Cultural Gerontology
2021 - Characteristics and Outcomes of Parkinson's Disease Individuals Hospitalized with <scp>COVID</scp>‐19 in a New York City Hospital System
Movement Disorders Clinical Practice
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”